NCT06341634

Brief Summary

The goal of this observational study is to validate an AI algorithm's capability to differentiate the population with suicidal ideation from a control population using various multimodal variables, including voice analysis, facial emotions, natural language, and proteomics data. The primary research question it aims to answer is: Is it possible to identify suicidal ideation and suicide risk in adolescents early and non-intrusively using multimodal data analysis through digital instruments equipped with artificial intelligence? Participants in this study will be asked to: Complete psychometric instruments to establish a gold standard for detecting suicide risk and suicidal ideation. Provide voice recordings, facial emotion data, and linguistic content in natural and specific contexts. Participate in salivary proteomics data collection. This study compares three distinct groups: Ideation: Adolescent patients with current suicidal ideation. Clinical Population: Psychological or psychiatric patients of the same age and gender without suicidal ideation. General Population: Adolescents without known psychological or psychiatric pathology of the same age and gender, without suicidal ideation. Researchers will compare these groups to determine if the AI algorithm is effective in differentiating individuals with suicidal ideation (Group 1) from both a clinical control group (Group 2) and a general population control group (Group 3) using the collected multimodal data. The study aims to assess the algorithm's ability to identify early signs of suicide risk in these distinct participant populations.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
339

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

4 active sites

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 20, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

February 6, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 2, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

March 13, 2025

Status Verified

March 1, 2025

Enrollment Period

1.4 years

First QC Date

November 20, 2023

Last Update Submit

March 11, 2025

Conditions

Keywords

Suicide PreventionDistress, EmotionalAdolescent BehaviorArtificial IntelligenceProteomics

Outcome Measures

Primary Outcomes (5)

  • Strengths and Difficulties Questionnaire (SDQ)

    This questionnaire detects probable cases of mental and behavioral disorders in children and adolescents aged 4 to 17. A score \>19 points is considered positive in screening.

    through study completion, an average of 1 year

  • Mood and Feelings Questionnaire (MFQ)

    This questionnaire assesses symptoms of depression/suicide risk. Scores above 27 points are considered positive for screening. Higher values are indicative of worse outcomes.

    through study completion, an average of 1 year

  • Paykel Suicide Scale (PSS)

    This questionnaire asks about suicidal ideation over the past year. Scores equal to or greater than 4 are suggestive of suicidal ideation. Higher values are indicative of worse outcomes.

    through study completion, an average of 1 year

  • Facial microexpressions, voice and linguistic content analysis

    Participants will be asked to speak in front of a camera about their emotional state over the past week. The recording will have a minimum duration of 2 minutes and will be used for voice analysis, facial microexpressions, and natural language processing (NLP) for linguistic content analysis. Participants will also be asked to write a brief text on the computer in response to questions about how they perceive themselves and how they think others perceive them. The maximum duration for this exercise is 10 minutes.

    through study completion, an average of 1 year

  • Proteomic and stress level analysis

    The collection of saliva is performed in a simple, non-invasive, and painless manner, allowing for the subsequent retrieval of high-quality proteins for further analysis and studies.

    through study completion, an average of 1 year

Secondary Outcomes (3)

  • Millon Adolescent Clinical Inventory - II (MACI-II)

    through study completion, an average of 1 year

  • Problematic Internet Use Scale in Adolescents (EUPI-A)

    through study completion, an average of 1 year

  • European Bullying Intervention Project Questionnaire (EBIP-Q) and European Ciberbullying Intervention Project Questionnaire (ECIP-Q)

    through study completion, an average of 1 year

Other Outcomes (1)

  • Oviedo Response Infrequency Scale-Revised (INF-OV-R)

    through study completion, an average of 1 year

Study Arms (3)

Ideation

Patients with current suicidal ideation, recruited by staff doctors and psychologists from the child and adolescent psychiatry units of the Álvaro Cunqueiro Hospital in Vigo and the University Hospital Complex in Ourense, who have been deemed suitable for participation and have had the participation conditions explained to them and their parents, will undergo the following assessment protocol: Paykel scale Mini International Neuropsychiatric Interview (MINI) Strengths and Difficulties Questionnaire (SDQ) Mood and Feelings Questionnaire (MFQ) European Bullying Intervention Project Questionnaire (EBIP-Q) Problematic Internet Use Scale in Adolescents (EUPI-A) Millon Adolescent Clinical Inventory (MACI) Multimodal experimental battery: Recording of voice features Video recording of facial microexpression Registering of autobiographical texts Collecting of saliva samples

Clinical Population

Psychological or psychiatric patients, devoid of suicidal ideation, recruited by staff doctors and psychologists from the child and adolescent psychiatry units of the Álvaro Cunqueiro Hospital in Vigo and the University Hospital Complex in Ourense, who have been deemed suitable for participation and have had the participation conditions explained to them and their parents, will undergo the following assessment protocol: Paykel scale Mini International Neuropsychiatric Interview (MINI) Strengths and Difficulties Questionnaire (SDQ) Mood and Feelings Questionnaire (MFQ) European Bullying Intervention Project Questionnaire (EBIP-Q) Problematic Internet Use Scale in Adolescents (EUPI-A) Millon Adolescent Clinical Inventory (MACI) Multimodal experimental battery: Recording of voice features Video recording of facial microexpression Registering of autobiographical texts Collecting of saliva samples

General Population

Students with no known psychological or psychiatric issues, and free of suicidal ideation in the past year, recruited from schools among students who voluntarily agree to participate, and who have been deemed suitable for participation and have had the participation conditions explained to them and their parents, will undergo the following assessment protocol: Paykel scale Mini International Neuropsychiatric Interview (MINI) Strengths and Difficulties Questionnaire (SDQ) Mood and Feelings Questionnaire (MFQ) European Bullying Intervention Project Questionnaire (EBIP-Q) Problematic Internet Use Scale in Adolescents (EUPI-A) Millon Adolescent Clinical Inventory (MACI) Multimodal experimental battery: Recording of voice features Video recording of facial microexpression Registering of autobiographical texts Collecting of saliva samples

Eligibility Criteria

Age11 Years - 16 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Adolescents aged between 11 and 16 years old from clinical and and general population.

You may qualify if:

  • Ideation Group
  • Participants must be between 11 and 16 years old.

You may not qualify if:

  • Patients receive care in child and adolescent psychiatry or psychology services and currently have suicidal ideation.
  • Patients may have a previous follow-up, as long as they have suicidal ideation at the present moment, or they may be new consultations and may be receiving pharmacological treatment (which will be documented in the study).
  • Clinical Population Group
  • Participants must be between 11 and 16 years old.
  • Patients have not had suicidal ideation in the past year. Patients may have a previous follow-up or may be new consultations, and they may be receiving pharmacological treatment (which will be documented in the study).
  • General Population Group
  • Participants must be between 11 and 16 years old.
  • Students must declare that they have not received psychiatric or psychological follow-up before, nor have they had suicidal ideation in the past year.
  • Neurodevelopmental disorders or speech disorders affecting verbal communication capacity, specifically including:
  • Autism Spectrum Disorder grades 2 and 3.
  • Communication disorders (selective mutism, language disorder, phonological disorder, childhood-onset fluency disorder, social communication disorder).
  • Individuals with hearing impairment and verbal language impairment.
  • Individuals with moderate and severe intellectual disabilities.
  • Individuals with psychotic disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Servizo Galego de Saúde

Santiago de Compostela, A Coruña, 15703, Spain

Location

Hospital Álvaro Cunqueiro

Vigo, Pontevedra, 36211, Spain

Location

University of Vigo

Vigo, Pontevedra, 36310, Spain

Location

University Hospital Complex of Ourense

Ourense, 36002, Spain

Location

Related Publications (47)

  • Abd-Alrazaq AA, Alajlani M, Alalwan AA, Bewick BM, Gardner P, Househ M. An overview of the features of chatbots in mental health: A scoping review. Int J Med Inform. 2019 Dec;132:103978. doi: 10.1016/j.ijmedinf.2019.103978. Epub 2019 Sep 25.

    PMID: 31622850BACKGROUND
  • Adamou M, Antoniou G, Greasidou E, Lagani V, Charonyktakis P, Tsamardinos I, Doyle M. Toward Automatic Risk Assessment to Support Suicide Prevention. Crisis. 2019 Jul;40(4):249-256. doi: 10.1027/0227-5910/a000561. Epub 2018 Nov 26.

    PMID: 30474411BACKGROUND
  • Bachmann S. Epidemiology of Suicide and the Psychiatric Perspective. Int J Environ Res Public Health. 2018 Jul 6;15(7):1425. doi: 10.3390/ijerph15071425.

    PMID: 29986446BACKGROUND
  • Briere J, Gil E. Self-mutilation in clinical and general population samples: prevalence, correlates, and functions. Am J Orthopsychiatry. 1998 Oct;68(4):609-20. doi: 10.1037/h0080369.

    PMID: 9809120BACKGROUND
  • Brunner R, Kaess M, Parzer P, Fischer G, Carli V, Hoven CW, Wasserman C, Sarchiapone M, Resch F, Apter A, Balazs J, Barzilay S, Bobes J, Corcoran P, Cosmanm D, Haring C, Iosuec M, Kahn JP, Keeley H, Meszaros G, Nemes B, Podlogar T, Postuvan V, Saiz PA, Sisask M, Tubiana A, Varnik A, Wasserman D. Life-time prevalence and psychosocial correlates of adolescent direct self-injurious behavior: a comparative study of findings in 11 European countries. J Child Psychol Psychiatry. 2014 Apr;55(4):337-48. doi: 10.1111/jcpp.12166. Epub 2013 Nov 12.

    PMID: 24215434BACKGROUND
  • Choi D, Sumner SA, Holland KM, Draper J, Murphy S, Bowen DA, Zwald M, Wang J, Law R, Taylor J, Konjeti C, De Choudhury M. Development of a Machine Learning Model Using Multiple, Heterogeneous Data Sources to Estimate Weekly US Suicide Fatalities. JAMA Netw Open. 2020 Dec 1;3(12):e2030932. doi: 10.1001/jamanetworkopen.2020.30932.

    PMID: 33355678BACKGROUND
  • Krageloh CU, Czuba KJ, Billington DR, Kersten P, Siegert RJ. Using feedback from patient-reported outcome measures in mental health services: a scoping study and typology. Psychiatr Serv. 2015 Mar 1;66(3):224-41. doi: 10.1176/appi.ps.201400141. Epub 2014 Dec 1.

    PMID: 25727110BACKGROUND
  • Gillies D, Christou MA, Dixon AC, Featherston OJ, Rapti I, Garcia-Anguita A, Villasis-Keever M, Reebye P, Christou E, Al Kabir N, Christou PA. Prevalence and Characteristics of Self-Harm in Adolescents: Meta-Analyses of Community-Based Studies 1990-2015. J Am Acad Child Adolesc Psychiatry. 2018 Oct;57(10):733-741. doi: 10.1016/j.jaac.2018.06.018. Epub 2018 Aug 21.

    PMID: 30274648BACKGROUND
  • Coppersmith G, Leary R, Crutchley P, Fine A. Natural Language Processing of Social Media as Screening for Suicide Risk. Biomed Inform Insights. 2018 Aug 27;10:1178222618792860. doi: 10.1177/1178222618792860. eCollection 2018.

    PMID: 30158822BACKGROUND
  • Czeisler ME, Lane RI, Petrosky E, Wiley JF, Christensen A, Njai R, Weaver MD, Robbins R, Facer-Childs ER, Barger LK, Czeisler CA, Howard ME, Rajaratnam SMW. Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic - United States, June 24-30, 2020. MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1049-1057. doi: 10.15585/mmwr.mm6932a1.

    PMID: 32790653BACKGROUND
  • Deveci A, Aydemir O, Taskin O, Taneli F, Esen-Danaci A. Serum BDNF levels in suicide attempters related to psychosocial stressors: a comparative study with depression. Neuropsychobiology. 2007;56(2-3):93-7. doi: 10.1159/000111539. Epub 2007 Nov 23.

    PMID: 18037819BACKGROUND
  • Fernandez-Martinez I, Morales A, Mendez FX, Espada JP, Orgiles M. Spanish Adaptation and Psychometric Properties of the Parent Version of the Short Mood and Feelings Questionnaire (SMFQ-P) in a Non-Clinical Sample of Young School-Aged Children. Span J Psychol. 2020 Nov 5;23:e45. doi: 10.1017/SJP.2020.47.

    PMID: 33148355BACKGROUND
  • Garcia de la Garza A, Blanco C, Olfson M, Wall MM. Identification of Suicide Attempt Risk Factors in a National US Survey Using Machine Learning. JAMA Psychiatry. 2021 Apr 1;78(4):398-406. doi: 10.1001/jamapsychiatry.2020.4165.

    PMID: 33404590BACKGROUND
  • Golan O, Baron-Cohen S, Hill J. The Cambridge Mindreading (CAM) Face-Voice Battery: Testing complex emotion recognition in adults with and without Asperger syndrome. J Autism Dev Disord. 2006 Feb;36(2):169-83. doi: 10.1007/s10803-005-0057-y.

    PMID: 16477515BACKGROUND
  • Hawgood J, De Leo D. Suicide Prediction - A Shift in Paradigm Is Needed. Crisis. 2016 Jul;37(4):251-255. doi: 10.1027/0227-5910/a000440. No abstract available.

    PMID: 27809591BACKGROUND
  • Jacobson CM, Gould M. The epidemiology and phenomenology of non-suicidal self-injurious behavior among adolescents: a critical review of the literature. Arch Suicide Res. 2007;11(2):129-47. doi: 10.1080/13811110701247602.

    PMID: 17453692BACKGROUND
  • Johnston JN, Campbell D, Caruncho HJ, Henter ID, Ballard ED, Zarate CA. Suicide Biomarkers to Predict Risk, Classify Diagnostic Subtypes, and Identify Novel Therapeutic Targets: 5 Years of Promising Research. Int J Neuropsychopharmacol. 2022 Mar 17;25(3):197-214. doi: 10.1093/ijnp/pyab083.

    PMID: 34865007BACKGROUND
  • Kaess M, Parzer P, Haffner J, Steen R, Roos J, Klett M, Brunner R, Resch F. Explaining gender differences in non-fatal suicidal behaviour among adolescents: a population-based study. BMC Public Health. 2011 Jul 28;11:597. doi: 10.1186/1471-2458-11-597.

    PMID: 21794184BACKGROUND
  • Kamali M, Saunders EF, Prossin AR, Brucksch CB, Harrington GJ, Langenecker SA, McInnis MG. Associations between suicide attempts and elevated bedtime salivary cortisol levels in bipolar disorder. J Affect Disord. 2012 Feb;136(3):350-8. doi: 10.1016/j.jad.2011.11.027. Epub 2011 Dec 10.

    PMID: 22154566BACKGROUND
  • Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 2002 Mar 15;109(2):143-8. doi: 10.1016/s0165-1781(02)00005-7.

    PMID: 11927139BACKGROUND
  • Kouter K, Videtic Paska A. 'Omics' of suicidal behaviour: A path to personalised psychiatry. World J Psychiatry. 2021 Oct 19;11(10):774-790. doi: 10.5498/wjp.v11.i10.774. eCollection 2021 Oct 19.

    PMID: 34733641BACKGROUND
  • Lo Moro G, Soneson E, Jones PB, Galante J. Establishing a Theory-Based Multi-Level Approach for Primary Prevention of Mental Disorders in Young People. Int J Environ Res Public Health. 2020 Dec 16;17(24):9445. doi: 10.3390/ijerph17249445.

    PMID: 33339317BACKGROUND
  • Meadows R, Hine C, Suddaby E. Conversational agents and the making of mental health recovery. Digit Health. 2020 Nov 20;6:2055207620966170. doi: 10.1177/2055207620966170. eCollection 2020 Jan-Dec.

    PMID: 33282335BACKGROUND
  • Miranda-Mendizabal A, Castellvi P, Pares-Badell O, Alayo I, Almenara J, Alonso I, Blasco MJ, Cebria A, Gabilondo A, Gili M, Lagares C, Piqueras JA, Rodriguez-Jimenez T, Rodriguez-Marin J, Roca M, Soto-Sanz V, Vilagut G, Alonso J. Gender differences in suicidal behavior in adolescents and young adults: systematic review and meta-analysis of longitudinal studies. Int J Public Health. 2019 Mar;64(2):265-283. doi: 10.1007/s00038-018-1196-1. Epub 2019 Jan 12.

    PMID: 30635683BACKGROUND
  • Navarro MC, Ouellet-Morin I, Geoffroy MC, Boivin M, Tremblay RE, Cote SM, Orri M. Machine Learning Assessment of Early Life Factors Predicting Suicide Attempt in Adolescence or Young Adulthood. JAMA Netw Open. 2021 Mar 1;4(3):e211450. doi: 10.1001/jamanetworkopen.2021.1450.

    PMID: 33710292BACKGROUND
  • Nock MK, Kazdin AE. Examination of affective, cognitive, and behavioral factors and suicide-related outcomes in children and young adolescents. J Clin Child Adolesc Psychol. 2002 Mar;31(1):48-58. doi: 10.1207/S15374424JCCP3101_07.

    PMID: 11845650BACKGROUND
  • Pacheco-Lorenzo MR, Valladares-Rodriguez SM, Anido-Rifon LE, Fernandez-Iglesias MJ. Smart conversational agents for the detection of neuropsychiatric disorders: A systematic review. J Biomed Inform. 2021 Jan;113:103632. doi: 10.1016/j.jbi.2020.103632. Epub 2020 Dec 2.

    PMID: 33276112BACKGROUND
  • Pandey GN, Dwivedi Y, Rizavi HS, Ren X, Zhang H, Pavuluri MN. Brain-derived neurotrophic factor gene and protein expression in pediatric and adult depressed subjects. Prog Neuropsychopharmacol Biol Psychiatry. 2010 May 30;34(4):645-51. doi: 10.1016/j.pnpbp.2010.03.003. Epub 2010 Mar 20.

    PMID: 20227453BACKGROUND
  • Pinon-Blanco A, Vergara-Moragues E, Fernandez-Martinez R, Gutierrez-Martinez O, Alvarez-Counago M, Martinez-Reglero C, Rivera-Baltanas T, Otero-Lamas F, Olivares-Diez J, Spuch-Calvar C. Effectiveness of the “Trisquel” board game intervention program for patients with schizophrenia spectrum disorders. Actas Esp Psiquiatr. 2020 Sep;48(5):209-219. Epub 2020 Sep 1.

    PMID: 33210279BACKGROUND
  • Ramirez-Cifuentes D, Freire A, Baeza-Yates R, Punti J, Medina-Bravo P, Velazquez DA, Gonfaus JM, Gonzalez J. Detection of Suicidal Ideation on Social Media: Multimodal, Relational, and Behavioral Analysis. J Med Internet Res. 2020 Jul 7;22(7):e17758. doi: 10.2196/17758.

    PMID: 32673256BACKGROUND
  • Rao ML, Hawellek B, Papassotiropoulos A, Deister A, Frahnert C. Upregulation of the platelet Serotonin2A receptor and low blood serotonin in suicidal psychiatric patients. Neuropsychobiology. 1998;38(2):84-9. doi: 10.1159/000026522.

    PMID: 9732208BACKGROUND
  • Roe D, Mazor Y, Gelkopf M. Patient-reported outcome measurements (PROMs) and provider assessment in mental health: a systematic review of the context of implementation. Int J Qual Health Care. 2021 Mar 5;34(Suppl 1):ii28-ii39. doi: 10.1093/intqhc/mzz084.

    PMID: 31725153BACKGROUND
  • Rothe J, Buse J, Uhlmann A, Bluschke A, Roessner V. Changes in emotions and worries during the Covid-19 pandemic: an online-survey with children and adults with and without mental health conditions. Child Adolesc Psychiatry Ment Health. 2021 Feb 21;15(1):11. doi: 10.1186/s13034-021-00363-9.

    PMID: 33612122BACKGROUND
  • Spreux-Varoquaux O, Alvarez JC, Berlin I, Batista G, Despierre PG, Gilton A, Cremniter D. Differential abnormalities in plasma 5-HIAA and platelet serotonin concentrations in violent suicide attempters: relationships with impulsivity and depression. Life Sci. 2001 Jun 29;69(6):647-57. doi: 10.1016/s0024-3205(01)01158-4.

    PMID: 11476186BACKGROUND
  • Tsui FR, Shi L, Ruiz V, Ryan ND, Biernesser C, Iyengar S, Walsh CG, Brent DA. Natural language processing and machine learning of electronic health records for prediction of first-time suicide attempts. JAMIA Open. 2021 Mar 17;4(1):ooab011. doi: 10.1093/jamiaopen/ooab011. eCollection 2021 Jan.

    PMID: 33758800BACKGROUND
  • Vaidyam AN, Wisniewski H, Halamka JD, Kashavan MS, Torous JB. Chatbots and Conversational Agents in Mental Health: A Review of the Psychiatric Landscape. Can J Psychiatry. 2019 Jul;64(7):456-464. doi: 10.1177/0706743719828977. Epub 2019 Mar 21.

    PMID: 30897957BACKGROUND
  • Vallejo-Curto MDC, Rodrigues-Amorim D, Jardon-Golmar L, Blanco-Formoso M, Rivera-Baltanas T, Rodriguez-Jamardo C, Fernandez-Palleiro P, Alvarez-Ariza M, Lopez-Garcia M, Garcia-Caballero A, de Las Heras E, Olivares JM, Spuch C. Proteomic and metabolic profiling of chronic patients with schizophrenia induced by a physical activity program: Pilot study. Rev Psiquiatr Salud Ment (Engl Ed). 2021 Jul-Sep;14(3):125-138. doi: 10.1016/j.rpsmen.2021.07.002. Epub 2021 Aug 10.

    PMID: 34384726BACKGROUND
  • Voss C, Ollmann TM, Miche M, Venz J, Hoyer J, Pieper L, Hofler M, Beesdo-Baum K. Prevalence, Onset, and Course of Suicidal Behavior Among Adolescents and Young Adults in Germany. JAMA Netw Open. 2019 Oct 2;2(10):e1914386. doi: 10.1001/jamanetworkopen.2019.14386.

    PMID: 31664450BACKGROUND
  • Zhang Y, Zhang O, Wu Y, Lee HJ, Xu J, Xu H, Roberts K. Psychiatric symptom recognition without labeled data using distributional representations of phrases and on-line knowledge. J Biomed Inform. 2017 Nov;75S:S129-S137. doi: 10.1016/j.jbi.2017.06.014. Epub 2017 Jun 15.

    PMID: 28624644BACKGROUND
  • Rial Boubeta A, Gomez Salgado P, Isorna Folgar M, Araujo Gallego M, Varela Mallou J. PIUS-a: Problematic Internet Use Scale in adolescents. Development and psychometric validation. Adicciones. 2015 Mar 1;27(1):47-63.

    PMID: 25879477BACKGROUND
  • Parkhi O., Vedaldi A., and Zisserman A.. 2015. Deep Face Recognition. In Proceedings of the British Machine Vision Conference (BMVC). 41.1-41.12.

    BACKGROUND
  • De Quiroga S, Riesgo M, Martín del Campo E, Pulido S, Rodrigo S. (2019) Impacto Socioeconómico de la depresión y el suicidio en España [Internet]. Rev Esp Econ Salud: 2019; 4(15).

    BACKGROUND
  • Stappen, L., Baird, A., Christ, L., Schumann, L., Sertolli, B., Messner, E., Cambria, E., Zhao, G., Schuller, Björn. (2021). The MuSe 2021 Multimodal Sentiment Analysis Challenge: Sentiment, Emotion, Physiological-Emotion, and Stress.

    BACKGROUND
  • Vekiri I. and Chronaki A. (2008) "Gender issues in technology use: Perceived social support, computer self-efficacy and value beliefs, and computer use beyond school," Comput. Educ., vol. 51, no. 3, pp. 1392-1404, 2008.

    BACKGROUND
  • World Health Organization (2014) Preventing suicide. A global imperative. Geneva: 2014.

    BACKGROUND
  • World Health Organisation (2021a) Comprehensive mental health action plan 2013-2030. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.

    BACKGROUND
  • World Health Organisation (2021b) Suicide in the world: global health estimates. 2019, 32 p., World Health Organization, Technical documents. WHO/MSD/MER/19.3.

    BACKGROUND

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

Saliva samples

MeSH Terms

Conditions

SuicideAdolescent BehaviorSuicide Prevention

Condition Hierarchy (Ancestors)

Self-Injurious BehaviorBehavioral SymptomsBehavior

Study Officials

  • Alejandro García Caballero

    University Hospital Complex of Ourense

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Coordinator of Mental Health Prevention/Promotion Programs

Study Record Dates

First Submitted

November 20, 2023

First Posted

April 2, 2024

Study Start

February 6, 2024

Primary Completion

June 30, 2025

Study Completion

September 30, 2025

Last Updated

March 13, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations